For instance, lncRNA MIR22HG is a critical inducer of the Wnt/β-catenin signaling pathway, which provides a potential therapeutic strategy for glioma patients by targeting the lncRNA MIR22HG [6]. The gene discussed is MIR22HG; the disease is central nervous system cancer.